Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 2
1999 5
2000 1
2001 3
2002 3
2003 1
2004 1
2005 1
2006 2
2008 1
2009 2
2010 4
2012 4
2013 3
2014 5
2015 2
2016 2
2017 2
2018 3
2019 1
2020 4
2021 6
2022 8
2023 7
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.
Perkovic V, Barratt J, Rovin B, Kashihara N, Maes B, Zhang H, Trimarchi H, Kollins D, Papachristofi O, Jacinto-Sanders S, Merkel T, Guerard N, Renfurm R, Hach T, Rizk DV; APPLAUSE-IgAN Investigators. Perkovic V, et al. N Engl J Med. 2025 Feb 6;392(6):531-543. doi: 10.1056/NEJMoa2410316. Epub 2024 Oct 25. N Engl J Med. 2025. PMID: 39453772 Clinical Trial.
Clinicopathologic Features of Mitochondrial Nephropathy.
Imasawa T, Hirano D, Nozu K, Kitamura H, Hattori M, Sugiyama H, Sato H, Murayama K; J-SMiN Collaborators. Imasawa T, et al. Kidney Int Rep. 2022 Jan 11;7(3):580-590. doi: 10.1016/j.ekir.2021.12.028. eCollection 2022 Mar. Kidney Int Rep. 2022. PMID: 35257070 Free PMC article.
Podocyte energy metabolism and glomerular diseases.
Imasawa T, Rossignol R. Imasawa T, et al. Int J Biochem Cell Biol. 2013 Sep;45(9):2109-18. doi: 10.1016/j.biocel.2013.06.013. Epub 2013 Jun 24. Int J Biochem Cell Biol. 2013. PMID: 23806869 Review.
SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study).
Kuwabara T, Miyasato Y, Kanki T, Mizumoto T, Matsubara T, Sawa N, Sugiyama H, Maruyama S, Sato H, Tsukamoto T, Murata T, Miyazaki M, Imasawa T, Mukoyama M, Murakami N, Jhaveri KD, Yanagita M; JSN Onconephrology working group. Kuwabara T, et al. Among authors: imasawa t. Clin Kidney J. 2024 Nov 28;17(12):sfae327. doi: 10.1093/ckj/sfae327. eCollection 2024 Dec. Clin Kidney J. 2024. PMID: 39664993 Free PMC article.
Role of T cells in murine IgA nephropathy.
Nagasawa R, Maruyama N, Imasawa T, Mitarai T. Nagasawa R, et al. Among authors: imasawa t. Nephrol Dial Transplant. 1999;14 Suppl 1:12-3. doi: 10.1093/ndt/14.suppl_1.12. Nephrol Dial Transplant. 1999. PMID: 10048438 Review. No abstract available.
Mesangial cell-predominant gene, megsin.
Inagi R, Miyata T, Imasawa T, Nangaku M, Kurokawa K. Inagi R, et al. Among authors: imasawa t. Nephrol Dial Transplant. 2002;17 Suppl 9:32-3. doi: 10.1093/ndt/17.suppl_9.32. Nephrol Dial Transplant. 2002. PMID: 12386281
74 results